Publications scientifiques sur les diagnostics non invasifs BioPredictive

Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.

22/435 Résultats pour
“STARD, Standards for the Reporting of Diagnostic Accuracy Studies”

“STARD, Standards for the Reporting of Diagnostic Accuracy Studies” Tout effacer
  1. FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.

    Munteanu M et al. · J Hepatol · 2011 Score 100

    FibroTest HBV HCV HIV

  2. Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

    Poynard T et al. · Diagnostics (Basel) · 2025 Score 98

    …An unmet need is to reduce the uncertainty of biomarkers for the

    FibroTest-T2D Metabolic

  3. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication Review

    Poynard T et al. · Gastroenterol Clin Biol · 2008 Score 96

    …As waiting for the perfect biomarker for the diagnosis of advanced fibrosis…

    ActiTest FibroTest SteatoTest Alcohol +5

  4. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV. Key publication

    Poynard T et al. · JHEP Rep · 2021 Score 94

    the negative predictive value (NPV) of LCR1-LCR2 for the occurrence of

    LCR1 LCR2 HCV

  5. Prognostic value of liver fibrosis biomarkers: a meta-analysis.

    Poynard T et al. · Gastroenterol Hepatol (N Y) · 2011 Score 91

    …4 (3 studies; 1,184 patients). For the prediction of survival without…

    FibroTest Alcohol HBV HCV +3

  6. Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

    Poynard T et al. · Curr Hepat Rep · 2011 Score 89

    …5 studies, 618 patients). For the diagnosis of advanced fibrosis, the standardized…

    FibroTest HBV

  7. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Key publication

    Poynard T et al. · Clin Chem · 2007 Score 87

    …as an estimate of the diagnostic value for fibrosis markers. Whether there…

    FibroTest HCV

  8. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication Meta Analysis

    Halfon P et al. · Gastroenterol Clin Biol · 2008 Score 85

    the prognostic value of FT in CHC, CHB and ALD. For diagnostic

    FibroTest Alcohol HBV HCV +2

  9. Meta-analyses of FibroTest diagnostic value in chronic liver disease. Key publication Meta Analysis

    Poynard T et al. · BMC Gastroenterol · 2007 Score 82

    The FT diagnostic value is similar for the diagnosis of intermediate and…

    FibroTest Alcohol HBV HCV +1

  10. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Meta Analysis

    Poynard T et al. · Gastroenterol Clin Biol · 2010 Score 80

    studies (2017 patients) were included. The overall accuracy of AT for the

    ActiTest HCV

  11. Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

    Caussy C et al. · Diabetes Care · 2025 Score 78

    The area under the empirical receiver operating characteristic curves of NITs for

    FibroTest Metabolic

  12. Assessment of liver fibrosis: noninvasive means.

    Poynard T et al. · Saudi J Gastroenterol · 2008 Score 75

    For FibroTest, the mean diagnostic value for the diagnosis of advanced fibrosis…

    FibroTest Alcohol HBV HCV +3

  13. Impact of steatosis and inflammation definitions on the performance of NASH tests.

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2018 Score 73

    …We reviewed the landmark studies in metabolic liver disease, sources of the

    ActiTest FibroTest NashTest NashTest-2 +3

  14. Biomarkers of liver fibrosis. Review

    Poynard T et al. · Adv Clin Chem · 2008 Score 71

    The mean diagnostic value for the diagnosis of advanced fibrosis assessed using…

    ActiTest FibroTest SteatoTest Alcohol +5

  15. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease. Key publication

    Thiele M et al. · Gastroenterology · 2018 Score 69

    …Secondary aims were to assess the diagnostic accuracy of ELF for significant…

    FibroTest Alcohol

  16. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Key publication

    Anastasiou J et al. · Eur J Gastroenterol Hepatol · 2010 Score 66

    ### Background The efficiency of transient elastography for the assessment of liver fibrosis…

    ActiTest FibroTest Alcohol HBV +3

  17. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Review

    Boursier J et al. · Eur J Gastroenterol Hepatol · 2009 Score 64

    …We evaluated their diagnostic accuracy, and how to increase it, for the

    FibroTest HCV

  18. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Key publication

    Munteanu M et al. · Aliment Pharmacol Ther · 2016 Score 62

    the validation of three blood tests used in NAFLD patients, FibroTest for

    ActiTest FibroTest SteatoTest Metabolic

  19. Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.

    Rudler M et al. · PLoS One · 2015 Score 60

    …validate the AshTest accuracy in the specific context of use of patients…

    AshTest Alcohol

  20. Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. Key publication

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2018 Score 57

    of this study was to construct a new quantitative test for the

    FibroTest NashTest SteatoTest Metabolic

  21. Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. Key publication

    Poynard T et al. · Aliment Pharmacol Ther · 2021 Score 55

    the ROC curve. ### Results The diagnostic performance of each component of the

    FibroTest NashTest-2 SteatoTest Metabolic

  22. Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Meta Analysis

    Houot M et al. · Aliment Pharmacol Ther · 2016 Score 53

    …we selected studies that directly compared the diagnostic accuracy of FibroTest, aspartate…

    FibroTest HBV HCV

Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.